Studies on antimicrobial activity of NM394 and clinical efficacy of NM441 in respiratory tract infection

Japanese Journal of Chemotherapy

Volumn 44, Issue SUPPL. 1, 1996, Pages 317-323

  Kurimura, Osamu ^a   Hiramoto, Takehiko ^a   Nakano, Kikuo ^a   Tominaga, Naoko ^a   Nozaki, Kimitoshi ^a   Maruyama, Taisuke ^a   Furui, Jun ^a   Doi, Hideyuki ^a   Kono, Michiko ^a   Shimonaka, Akiko ^a   Kondo, Mitsuko ^a   Koda, Tetsuzo ^b   Ichimura, Hiroshi ^b   Tamura, Ikuo ^b  

^a NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

^b NONE

Author keywords

NM394; NM441

Indexed keywords

6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID; CIPROFLOXACIN; FLEROXACIN; OFLOXACIN; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE LIVER FUNCTION RELATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; RASH; RESPIRATORY TRACT INFECTION;

EID: 15844394268     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Ozaki M, et al : In vitro antibacterial activity of a new quinolone, NM394. Antimicrob Agents Chemother 35 : 2490-2495, 1991
2. Chemotherapy 29 : 76-79, 1981